Medically reviewed by Dr. Jaramillo, a doctor at Goodweigh. Last updated on 8 October 2026
Short answer from Dr. Jaramillo
An alternative to Ozempic if you want to lose weight is Wegovy: it contains exactly the same active ingredient (semaglutide), but is officially authorised for the treatment of obesity. Mounjaro and Saxenda are the other main medical options, each with its own active ingredient and dosage schedule. Which treatment is right for you depends on your clinical profile, medical history and goals, and a Goodweigh doctor will determine this together with you during the intake.
Dr. Jaramillo, doctor at Goodweigh
Want to find out more? Start your intake here
If you’re looking for an alternative to Ozempic, your main options are Wegovy, Mounjaro and Saxenda. In this article, you’ll find out what these treatments have in common, how they differ, and what that means for weight management. We’ll also look at oral options, possible side effects and why natural supplements are no substitute for medically supervised care.
What is an alternative to Ozempic?
An alternative to Ozempic is another medicine from the same group that is approved for the treatment of obesity. Ozempic is intended for type 2 diabetes, not for weight loss. You can read more about that medicine in the blog post ‘What is Ozempic?’.
For obesity, these are Wegovy and Saxenda. Mounjaro is authorised for both type 2 diabetes and weight management. All three are administered by injection. Oral formulations are also in development or are being launched on international markets.
What is the difference between Ozempic, Wegovy, Mounjaro and Saxenda?
The main differences lie in the active ingredient, the approved indication and how often you take the injection. Ozempic and Wegovy contain semaglutide and are injected weekly. Saxenda contains liraglutide and is injected daily. Mounjaro contains tirzepatide and is injected weekly.
Semaglutide and liraglutide mimic the gut hormone GLP-1. Tirzepatide mimics not only GLP-1 but also the hormone GIP. All these medicines suppress your appetite and slow down the rate at which your stomach empties. As a result, you feel full sooner and for longer.
The table compares the key points side by side. The differences in weight are taken from various studies and therefore cannot be compared on a like-for-like basis.
Ozempic or Wegovy: what’s the difference?
Ozempic and Wegovy both contain semaglutide. You inject both once a week. The difference lies in what they are approved for: Ozempic for type 2 diabetes, Wegovy for obesity. Wegovy also comes in a higher dose, which is tailored to weight loss. If you want to lose weight, Wegovy is therefore the more obvious choice.
Wegovy or Mounjaro: which is more effective?
In a study published in The New England Journal of Medicine that directly compared the two, people lost more weight with Mounjaro. After nearly a year and a half, the average weight loss was around 20 per cent with Mounjaro and around 14 per cent with Wegovy.
Direct comparative studies remain scarce in the wider clinical literature (Annals of Internal Medicine). A Goodweigh doctor assesses your individual health profile rather than relying solely on averages from research. You can read more in the blog post ‘The differences between Mounjaro and Ozempic’.
Is Mounjaro or Wegovy an alternative to Saxenda?
Yes, and studies seem to suggest that both are more effective than Saxenda. You have to take Saxenda every day, whereas the other two are taken once a week.
Saxenda was compared directly with Wegovy in a study. In that study, after just over a year, people lost an average of 15.8 per cent of their body weight with Wegovy and 6.4 per cent with Saxenda. Furthermore, around half as many people stopped taking Wegovy. Read more in ‘What is Saxenda?’.
Wegovy tablets or Rybelsus: can you lose weight with GLP-1 medication without injections?
Yes, with the Wegovy tablet. This is a daily tablet containing semaglutide that is authorised for the treatment of obesity. According to the EMA, its safety profile appears to be similar to that of the weekly injection. You can find more information on the product page.
Rybelsus is also a semaglutide tablet, but it is only authorised for type 2 diabetes. You should take both tablets on an empty stomach and then wait at least 30 minutes before eating, drinking or taking any other medicines. You can find more information in the articles ‘Wegovy tablet and oral semaglutide’ and ‘Oral versus injectable semaglutide’.
Side effects of Ozempic, Wegovy, Mounjaro and Saxenda: what is the same and what is different?
The side effects are very similar, as those associated with tirzepatide are comparable to those of other GLP-1 agents. Nausea, vomiting, diarrhoea and constipation are very common with all three, affecting more than 1 in 10 people. They are usually most severe at the start and following a higher dose, and then subside.
Inflammation of the pancreas (pancreatitis) can sometimes occur. With Wegovy, this affects around 1 in 500 people. If you experience severe, persistent abdominal pain, contact a doctor immediately. If you are vomiting or have diarrhoea, it is important to drink plenty of fluids, as dehydration can affect your kidneys. There are also differences, such as cutaneous amyloidosis (a localised skin abnormality at the injection site), which is only listed for Saxenda. Read more in the section on the side effects of semaglutide, tirzepatide and Saxenda.
Are there any natural alternatives to Ozempic and other GLP-1 medicines?
No supplement or natural remedy has the same effect as these medicines. A healthy lifestyle forms the basis of any treatment, even when taken alongside medication, according to the NHG Standard on Obesity. This includes diet, exercise and sleep. The meta-analysis published in Diabetes, Obesity and Metabolism shows that the weight lost consists mainly of fat. Between a quarter and just over a third is muscle and other lean body mass. Eating enough protein and doing strength training help to maintain muscle mass.
As weight loss involves the loss of both fat and muscle mass, sufficient protein and strength training are essential to maintain your metabolism. These medicines are available on prescription only, following a medical assessment.
Switching to a different GLP-1 medication: when is it best not to, and who decides?
Never switch to a different medicine on your own. There is no fixed conversion between doses. That is why a doctor must always make the decision, and you will usually have to start the dose-escalation schedule again.
The doctor will assess your health, your other medicines and any previous conditions, such as pancreatitis. Switching requires extra caution if you are taking insulin or certain diabetes tablets, as your blood sugar levels may drop too low. At Goodweigh, you’ll gradually build up your dose of Wegovy and Mounjaro over 16 to 20 weeks, so that your body can get used to the medicine. Are you due to have surgery under general anaesthetic? If so, please let them know in advance that you’re taking this medicine.
How does Goodweigh help you choose between GLP-1 medicines?
Goodweigh combines medication with support from a doctor and a coach. Following your intake, the doctor will assess which medication is right for you. You can find out how the support works under ‘How it works’.
Frequently Asked Questions
What is the best alternative to Ozempic?
That varies from person to person. Wegovy contains the same active ingredient and is authorised for the treatment of obesity, whilst Mounjaro contains a different active ingredient. A doctor will determine which is right for you.
Is Wegovy the same as Ozempic?
No. Both contain semaglutide, but Ozempic is authorised for type 2 diabetes and Wegovy for obesity.
Is there an alternative to Ozempic that doesn’t involve injections?
There is a Wegovy tablet for weight loss. You can find more information on the product page. Rybelsus is a tablet for type 2 diabetes and is not a weight-loss medication.
Is Mounjaro an alternative to Saxenda?
Yes. You inject Mounjaro and Wegovy once a week, and Saxenda every day. In clinical trials, Wegovy resulted in greater weight loss than Saxenda.
Are there any natural alternatives to Ozempic?
No supplement works in the same way as these medicines. Eating healthily, exercising and getting a good night’s sleep remain the foundation.
Quellen
Eisa, N., et al. (2026). Lean mass changes with incretin therapy versus lifestyle intervention: A systematic review and meta-analysis of randomised controlled trials. Diabetes, Obesity and Metabolism, 28, 4818-4827. https://pubmed.ncbi.nlm.nih.gov/41877354/
- Moiz, A., et al. (2025). Efficacy and safety of glucagon-like peptide-1 receptor agonists for weight loss among adults without diabetes: A systematic review of randomized controlled trials. Annals of Internal Medicine, 178, 199-217. https://pubmed.ncbi.nlm.nih.gov/39761578/
- Nauck, M. A., et al. (2022). Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction. Cardiovascular Diabetology, 21, 169. https://pubmed.ncbi.nlm.nih.gov/36050763/
- Aronne, L. J., et al. (2025). Tirzepatide as compared with semaglutide for the treatment of obesity. New England Journal of Medicine, 393, 26-36. https://pubmed.ncbi.nlm.nih.gov/40353578/
- NHG. NHG-Standaard Obesitas (december 2025). https://richtlijnen.nhg.org/standaarden/obesitas
- European Medicines Agency. First oral GLP-1 treatment for weight management. https://www.ema.europa.eu/en/news/first-oral-glp-1-treatment-weight-management



